MIC B vitamin liquid 25/50/50/1/1/1mg/ml RX glass vial
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-D-0399-2019.
Lack of sterility assurance.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-D-0399-2019.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Hiers Enterprises, Llc Dba Northwest Compounding Pharmacy or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-D-0399-2019.
Hiers Enterprises, LLC dba Northwest Compounding Pharmacy
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Hiers Enterprises, Llc Dba Northwest Compounding Pharmacy Recall FAQ
Hiers Enterprises, Llc Dba Northwest Compounding Pharmacy is the subject of a supplements safety report: MIC B vitamin liquid 25/50/50/1/1/1mg/ml RX glass vial. The notice was published on January 2, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 310 units are potentially affected.